Mirum Pharmaceuticals MIRM 深 滬
等待開盤 10-06 09:30:00 美东时间
72.95
+1.200
+1.67%
華盛通- 最 高73.26
- 今 開71.78
- 成交量 49.04万股
- 最 低 71.13
- 昨 收 71.75
- 總市值 36.65亿
- 52周最高 78.095
- 市盈率 靜 --
- 換手率 0.98%
- 52周最低 36.8801
- 委 比 -86.72%
- 總股本 5023.76万
- 歷史最高 78.095
- 量 比 0.78
- 振 幅 2.97%
- 歷史最低 6.513
- 每 手 1
- 風險率 10.59%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 217美元！花旗上调阿里巴巴目标价；多家机构集体上调麦克森、美光科技等目标价
今日重点评级关注：Ascendiant Capital：维持Maison Solutions"买入"评级，目标价从4美元升至4.25美元；瑞穗：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至56美元
09-25 09:52
TD Cowen Initiates Coverage On Mirum Pharmaceuticals with Buy Rating, Announces Price Target of $95
TD Cowen analyst Joseph Thome initiates coverage on Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy rating and announces Price Target of $95.
09-25 00:01
美股大行评级 | 潜在涨幅280.95%！HC Wainwright & Co.上调Immix Biopharma目标价至8美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从7美元升至8美元；Maxim Group：上调CNS Pharma评级至"买入"，目标价20美元
09-15 11:13
Demystifying Mirum Pharmaceuticals: Insights From 6 Analyst Reviews
Providing a diverse range of perspectives from bullish to bearish, 6 analysts h...
09-12 21:01
JP Morgan Maintains Overweight on Mirum Pharmaceuticals, Raises Price Target to $77
JP Morgan analyst Jessica Fye maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Overweight and raises the price target from $53 to $77.
09-12 19:16
Stifel Reinstates Buy on Mirum Pharmaceuticals, Announces $89 Price Target
Stifel analyst Dae Gon Ha reinstates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and announces $89 price target.
08-11 19:11
Deep Dive Into Mirum Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
In the last three months, 6 analysts have published ratings on Mirum Pharmaceut...
08-09 02:02
What to Expect from Kymera Therapeutics's Earnings
Kymera Therapeutics (NASDAQ:KYMR) is gearing up to announce its quarterly earni...
08-08 23:01
Mirium Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance above estimates.
Mirium Pharmaceuticals shares are trading higher after the company reported bet...
08-07 05:00
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
